DS Pharma Services: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
DS Pharma Services
Largest movements
- Tangible fixed assets -€24,382
down €24,382 (-11.9%), from €204,489 to €180,107
of which Land and buildings: -€19,500
- Current investments -€21,050
down €21,050 (-9.3%), from €225,268 to €204,218
- Receivables within one year +€14,509
up €14,509 (+3.5%), from €412,635 to €427,144
of which Trade receivables: +€17,565
- Debts after one year -€47,752
down €47,752 (-36.6%), from €130,505 to €82,753
- Reserves +€31,844
up €31,844 (+6.1%), from €518,726 to €550,569
of which Distributable reserves: +€31,844
- Other debts -€31,659
down €31,659 (-47.2%), from €67,009 to €35,350
- Tax, wage and social debts +€9,851
up €9,851 (+310%), from €3,174 to €13,025
- Gross operating margin +€38,503
up €38,503 (+203%), from €18,923 to €57,426
- Financial income +€17,652
new in 2025: €17,652
- Taxes +€5,330
up €5,330 (+4,276%), from €125 to €5,455
- Depreciation -€3,105
down €3,105 (-11.0%), from €28,249 to €25,144
- Other operating charges +€2,930
up €2,930 (+546%), from €536 to €3,467
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €881,001 | €850,197 | -€30,803 | -3.5% |
| Fixed assets | 21/28 | €204,489 | €180,107 | -€24,382 | -11.9% |
| Tangible fixed assets | 22/27 | €204,489 | €180,107 | -€24,382 | -11.9% |
| Land and buildings | 22 | €181,604 | €162,104 | -€19,500 | -10.7% |
| Plant, machinery and equipment | 23 | €22,886 | €18,003 | -€4,882 | -21.3% |
| Furniture and vehicles | 24 | €0 | - | = | |
| Current assets | 29/58 | €676,511 | €670,090 | -€6,421 | -0.9% |
| Amounts receivable within one year | 40/41 | €412,635 | €427,144 | +€14,509 | +3.5% |
| Trade receivables | 40 | €13,847 | €31,412 | +€17,565 | +127% |
| Other amounts receivable | 41 | €398,788 | €395,732 | -€3,057 | -0.8% |
| Current investments | 50/53 | €225,268 | €204,218 | -€21,050 | -9.3% |
| Cash at bank and in hand | 54/58 | €38,176 | €37,929 | -€248 | -0.6% |
| Deferred charges and accrued income | 490/1 | €432 | €800 | +€368 | +85.2% |
| Total equity and liabilities | 10/49 | €881,001 | €850,197 | -€30,803 | -3.5% |
| Equity | 10/15 | €635,085 | €666,928 | +€31,844 | +5.0% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Reserves | 13 | €518,726 | €550,569 | +€31,844 | +6.1% |
| Non-distributable reserves | 130/1 | €0 | - | = | |
| Reserves not available under the articles | 1311 | €0 | - | = | |
| Distributable reserves | 133 | €518,726 | €550,569 | +€31,844 | +6.1% |
| Profit (loss) carried forward | 14 | €110,159 | €110,159 | = | 0.0% |
| Amounts payable | 17/49 | €245,916 | €183,269 | -€62,647 | -25.5% |
| Amounts payable after more than one year | 17 | €130,505 | €82,753 | -€47,752 | -36.6% |
| Financial debts | 170/4 | €130,505 | €82,753 | -€47,752 | -36.6% |
| Amounts payable within one year | 42/48 | €115,364 | €96,410 | -€18,954 | -16.4% |
| Current portion of amounts payable after more than one year | 42 | €43,930 | €45,495 | +€1,565 | +3.6% |
| Trade debts | 44 | €1,252 | €2,540 | +€1,289 | +103% |
| Suppliers | 440/4 | €1,252 | €2,540 | +€1,289 | +103% |
| Taxes, remuneration and social security | 45 | €3,174 | €13,025 | +€9,851 | +310% |
| Taxes | 450/3 | €3,174 | €13,025 | +€9,851 | +310% |
| Other amounts payable | 47/48 | €67,009 | €35,350 | -€31,659 | -47.2% |
| Accrued charges and deferred income | 492/3 | €46 | €4,105 | +€4,059 | +8,794% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €28,249 | €25,144 | -€3,105 | -11.0% |
| Other operating charges | 640/8 | €536 | €3,467 | +€2,930 | +546% |
| Gross operating margin | 9900 | €18,923 | €57,426 | +€38,503 | +203% |
| Operating profit (loss) | 9901 | -€9,863 | €28,816 | +€38,678 | |
| Financial income | 75/76B | - | €17,652 | +€17,652 | |
| Recurring financial income | 75 | - | €17,652 | +€17,652 | |
| Financial charges | 65/66B | €7,687 | €9,169 | +€1,482 | +19.3% |
| Recurring financial charges | 65 | €7,687 | €9,169 | +€1,482 | +19.3% |
| Profit (loss) for the period before taxes | 9903 | -€17,550 | €37,298 | +€54,848 | |
| Income taxes | 67/77 | €125 | €5,455 | +€5,330 | +4,276% |
| Profit (loss) for the period | 9904 | -€17,675 | €31,844 | +€49,518 | |
| Profit (loss) for the period to be appropriated | 9905 | -€17,675 | €31,844 | +€49,518 |
Source: filed annual accounts (NBB), financial years ended 31 March 2024 and 31 March 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 17 October 2026 via checked.be.